Skip to content
Search

Latest Stories

Doctors urge children under 8 to avoid slushies due to glycerol risks

Slushy drinks may look fun, but hidden glycerol risks mean parents should stay cautious

slushies

Slushy drinks attract young children with their bright colours and taste

istock

Children’s love for brightly coloured, sweet beverages, such as slushy ice drinks, may come with hidden dangers, according to new research that highlights the risks posed by glycerol, a common ingredient in these products. Doctors are now urging that children under eight should completely avoid slushy drinks that contain glycerol, as they may cause serious health issues, including loss of consciousness and shock.

The call for revised health advice comes in response to a recent study conducted by paediatricians in the UK and Ireland. The research, published in the journal Archives of Disease in Childhood, examined 21 cases of children aged between two and seven who required emergency treatment shortly after drinking glycerol-containing slushies. These cases, all from 2018 to 2024, involved children who became acutely ill within an hour of consuming the drinks.


Glycerol intoxication: The hidden danger

Slushy drinks are often marketed to appeal to young children due to their vibrant colours and refreshing taste. Most parents are unaware, however, that many of these beverages replace sugar with glycerol, a naturally occurring sweetener used to prevent the drink from freezing solid. Glycerol gives slushies their signature semi-frozen texture, but in young children, it can lead to a condition doctors are calling “glycerol intoxication syndrome.”

The symptoms of glycerol intoxication can vary, but in all 21 children studied, the results were serious enough to warrant a visit to Accident & Emergency (A&E). The children exhibited a range of alarming symptoms: most lost consciousness, many experienced hypoglycaemia (low blood sugar), and some showed signs of high acidity in their blood. Four children required brain scans, and one suffered a seizure. Although all the children in the study eventually recovered, their experience highlights the potential severity of this issue.

Current advice and proposed changes

The Food Standards Agency (FSA) in the UK currently advises that children under five should avoid slushy drinks, while those aged five to 11 should consume them in moderation, with no more than one serving recommended. This advice stems from concerns that drinking slushies too quickly can lead to rapid glycerol absorption, which in turn may cause hypoglycaemia, shock, or even loss of consciousness.

However, the new study’s authors believe that this advice does not go far enough. Lead author Professor Ellen Crushell, from Dublin, warned that the 21 cases studied may only represent the "tip of the iceberg." She speculated that many more children could be suffering from milder symptoms, such as nausea and vomiting, that do not require hospitalisation but still result from glycerol consumption.

Because of the difficulty in determining a safe amount of glycerol for children, researchers are calling for clearer, age-based recommendations. At present, it is almost impossible for parents to assess how much glycerol a slushy contains or how quickly their child will drink it. Factors such as a child's weight, the speed of consumption, and whether the drink is taken with food or after exercise all play a role in how the body reacts. With so many variables, the researchers suggest that a simple age limit of eight years old could be an effective way to prevent these adverse reactions.

Parental concerns and the industry’s role

One reason slushies remain popular with parents is their lower sugar content, especially in countries like the UK, which has a sugar tax. Many of these drinks now rely on glycerol instead of glucose to create their texture, which parents often perceive as a healthier option. In countries without a sugar tax, slushies tend to contain higher levels of glucose and little to no glycerol, thus avoiding the risk of glycerol intoxication altogether.

Stricter regulations will be put in place to safeguard young consumersiStock

Dr Sally Anne Wilson, chair of the Royal College of Emergency Medicine's safer care committee, explained the dilemma facing parents: “As a parent, you want to make sensible decisions for what you buy your child, but if you’re not aware of the risks of glycerol, you won’t think twice about buying a slushy.” She emphasised that many parents do not know these drinks contain glycerol, let alone the dangers associated with it.

Wilson also acknowledged that giving advice based on a child’s age rather than weight might simplify matters for parents. While children's weights can vary significantly within the same age group, an age-based recommendation would be easier to follow and help minimise the risk of glycerol-related incidents.

A need for action

The study has already prompted the Food Standards Agency to reconsider its current guidance on slushy drinks. Rebecca Sudworth, the FSA’s director of policy, said the agency was reviewing the findings carefully and reiterated the importance of following existing recommendations. “We continue to strongly encourage parents to follow our advice, which is that slushy drinks should not be given to children under four years old,” she said. Retailers are also advised to communicate this guidance to customers.

More For You

Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less
Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images

Tennis champion Monica Seles reveals living with myasthenia gravis

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Keep ReadingShow less
faulty knee implant NHS recall

Hundreds of patients required corrective surgery

iStock

Faulty knee implant recalled after being used in over 10,000 NHS surgeries

Highlights:

  • NexGen knee implant linked to high failure rates was used in over 10,000 UK operations.
  • Concerns flagged as early as 2014; withdrawn from UK market in 2022.
  • Hundreds of patients required corrective surgery, with costs running into millions.
  • Manufacturer Zimmer Biomet says patient safety is its “top priority” but will not cover revision costs up front.

Implant used despite early warnings

A knee replacement implant used in thousands of NHS operations was known to have a concerning failure rate eight years before it was withdrawn, a BBC File on 4 Investigates report has found.

The NexGen implant, made by US manufacturer Zimmer Biomet, was fitted in more than 10,000 patients between 2012 and 2022. Concerns were first raised by the National Joint Registry (NJR) in 2014, though insufficient data at the time made it difficult to draw firm conclusions.

Keep ReadingShow less
health

A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV

iStock

Oral sex linked to skin cancer risk through stealth HPV infections, scientists warn

Highlights:

  • HPV, a common STI, is now potentially linked to a deadly form of skin cancer
  • A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV
  • Researchers say this discovery could shift the approach to diagnosing and treating some skin cancers
  • Protection measures include vaccination, safe sex practices, and regular screening


Human papillomavirus (HPV), one of the most widespread sexually transmitted infections in the UK, is already associated with several serious cancers — cervical, throat, penile, anal, and head and neck cancers among them. Now, researchers in the US have raised concerns that it may also contribute to certain forms of skin cancer, especially in people with weakened immune systems.

Scientists from the National Institutes of Health (NIH) found signs of beta-HPV triggering squamous cell carcinoma in a young woman who had no major history of sun damage or other typical causes.

Keep ReadingShow less
CardioPrecision

The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes

MediaZoo

CardioPrecision performs world-first robot-assisted aortic valve replacement via neck incision

Highlights:

  • Glasgow-based CardioPrecision completes first clinical cases of robotic aortic valve replacement (AVR) through a small neck incision.
  • The procedure was carried out at Cleveland Clinic in the United States.
  • It uses the company’s CoreVista® Robot Enabling Platform to perform minimally invasive surgery.
  • The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes.
  • Early results presented at major international conferences show clinical promise.


Glasgow medtech firm CardioPrecision has successfully performed the world’s first clinical cases of robot-assisted aortic valve replacement (AVR) using a small transcervical incision. This breakthrough could significantly reduce the need for traditional open-heart surgery.

The pioneering operations were carried out at the Cleveland Clinic in the United States, a centre globally recognised for its cardiovascular care. The procedures used CardioPrecision’s proprietary CoreVista® Robot Enabling Platform, offering a new route for accessing the heart valve via the neck rather than the chest.

Keep ReadingShow less